CONTEXT: No great surprise the MS patients are at a higher risk of infections, but good use of retrospective data analyses to see exactly what is going on – well Continue Reading
CONTEXT: Summary article on the continuing interest and need for RWR, fuelled by the COVID pandemic. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 5 1. Continue Reading
CONTEXT: A company looking to explore new ways to expand the use of RWD in drug development. By utilising the power of RWD to look at treatment models overall, it Continue Reading
CONTEXT: Commercial announcement of an RWE market analysis report. Unsurprisingly buoyant predictions of double digit growth forecasts across the board. IMPACT: low READ TIME: 5 mins Quality Level Mean [1 – Continue Reading
CONTEXT: Very interesting peer reviewed paper looking at RWD in randomised trials | A huge amount of information to get your teeth into here, but the conclusions suggest RCT fans Continue Reading
CONTEXT: Commercial announcement of an updated RWE platform for collection of prospective study data along with external data sources from another leading RWE company (It must be getting crowded up Continue Reading
CONTEXT: USA | Office for Human Research Protections (OHRP) has released a new informational video to help parents understand the importance [and implications] of Paediatric Research | Just as a Continue Reading
CONTEXT: Commercial announcement of another player in the RWE dataset market | The competition for people’s data is hotting up and you can get a sense for how valuable the Continue Reading
CONTEXT: Peer reviewed article | RWR uncovering potential diagnostic bias in NASH diagnoses again illustrates the power of large data sets in real-world settings to help physicians target the best Continue Reading
CONTEXT: Peer reviewed article on RWE in multiple myeloma | Pre-publication preview IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: 4 1. “We evaluated clinical outcomes among Continue Reading
